Xinya Tong

481 citations
12 papers · 332 indexed · h-index 7
Topics
RNA modifications and cancer (9 papers)Cancer-related molecular mechanisms research (8 papers)RNA Research and Splicing (5 papers)
Journals
SHILAP Revista de lepidopterologíaFrontiers in ImmunologyCell Death and Disease
Partner nations
China

In The Last Decade

Xinya Tong

12 papers receiving 330 citations

Peers

Xinya Tong
Comparison fields: 5 of 35
  • Molecular Biology 313
  • Cancer Research 183
  • Oncology 26
  • Pulmonary and Respiratory Medicine 20
  • Immunology 12
Replace Pengchao Li with:
Pengchao Li China
Bingrui Yan China
Yunhe Yu China
Xiaotong Bo China
Guohua Zhang China
Yiran Zou China
Minjeong Ko United States
Huajun Qu China
Annita Louloupi Denmark
Junge Deng China
Xinya Tong relative to Pengchao Li China Pengchao Li's profile →
Citations per field
00.5×8.7×
Pengchao Li · 1×
Citations per year

Countries citing papers authored by Xinya Tong

Since Specialization
Citations

This map shows the geographic impact of Xinya Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinya Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinya Tong more than expected).

Fields of papers citing papers by Xinya Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinya Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinya Tong. The network helps show where Xinya Tong may publish in the future.

Co-authorship network of co-authors of Xinya Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Xinya Tong. A scholar is included among the top collaborators of Xinya Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinya Tong. Xinya Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2 3
3 6
4 2
5 18
6
Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
1
7 10
8 29
9 154
10 4
11 62
12 41

About Xinya Tong

Xinya Tong is a scholar working on Cancer Research, Molecular Biology and Parasitology, having authored 12 papers that have together received 332 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (183 citations), Molecular Biology (313 citations) and Oncology (26 citations). Xinya Tong has collaborated with scholars based in China. Frequent co-authors include Xiangyang Xue, Xinyu Shi, Yuanbo Hu, Gangqiang Guo, Lele Ye, Chenbin Chen, Bujian Pan, Xian Shen, Sian Chen and Mingdong Lu. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026